Relevant bibliographies by topics / Hospital; drug

Academic literature on the topic 'Hospital; drug'

Author: Grafiati
Published: 10 December 2022
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hospital; drug.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hospital; drug"

1

Iqbal, Syed Talat, Zainab Batool, Haseeba Amir, and Tamkenat Mansoor. "DRUG-DRUG INTERACTIONS;." Professional Medical Journal 21, no. 03 (June 10, 2014): 441–44. http://dx.doi.org/10.29309/tpmj/2014.21.03.2018.

Full text
Abstract:
Introduction: This research paper is based on a study conducted on the in-doorpatients at a teaching hospital in Gujrat, Pakistan, in order to check for the frequency with whichPenicillins, Quinolones and Cephalosporins are being used together and in combinations withother drugs and the drug-drug interactions that occur due to these combinations and theirimpacts on the patients. Objectives: (1) To check the frequency with which Penicillins,Quinolone and Cephalosporins are being used in different combinations in patients. (2) Todetermine their drug-drug interactions. (3) Impact on patients due to these interactions. (4)Reasons for prescription of mismatched combinations by clinicians. Study Design: 270 randomprescriptions were collected from different wards of DHQ hospital, Gujrat. These prescriptionswere then analyzed for drug interactions among the above mentioned group of drugs, with thehelp of soft ware program named The Medical Letter Adverse Drug Interaction Program. Setting:Aziz Bhatti Shaheed Hospital (DHQ), Gujrat , Pakistan. Period: Prescriptions were collected overthe period of 3 months. Conclusions: Prescribing antibiotics for different indications in indoorpatients is unavoidable. However, it is the duty of the clinician to monitor the patient when he isusing two or more drugs together. This study recommends the use of drug-drug interactiondetecting software in hospitals, so that, the level of patients’ safety may be enhanced.
APA, Harvard, Vancouver, ISO, and other styles
2

Suiyati, Waode, and Sunarto S. "Analysis Of Drug Distribution System In Hospital Hospital Karanganyar." International Journal of Health and Pharmaceutical (IJHP) 2, no. 4 (August 11, 2022): 756–60. http://dx.doi.org/10.51601/ijhp.v2i4.107.

Full text
Abstract:
Inpatient drug services start from prescribing to patients, using drugs during treatment, until the patient returns home, there may be replacements, additional drugs and residual drugs. Although this service process is the responsibility of pharmacists, it is closely related to the role of medical personnel, nurses and the administrative division in hospitals. Research objectives Identify the percentagecompatibility between drugs and stock cards,IdentifyTurnover ratio,Identifypercentage of expired/damaged drug value,Identifythe average time used to serve prescriptions to the hands of patients,Identifypercentage of drugs served at the Karanganyar District Hospital.This research was conducted by following a descriptive research design to analyze the drug distribution system in the Inpatient Hospital of Karanganyar Regency. The data obtained in the form of primary data and secondary data. The research results arePercentage of matches between drugs and card stockis 86.6% with the indicator set is 100% it can be said to have not been effective when compared to indicators,Turn over ratio valueis 9 times turnover, the standard indicator is 8-12x capital turnover in 1 year. This means that the TOR is effective,Percentage of expired/damaged drug valueis 4.5% and the standard indicator of 0% means that it can be said to be ineffective, The average time used to serve prescriptions to the hands of patientsThe long waiting time for compound drugs is in stage II, which is 36.28 minutes, and the waiting time for non-concoction drugs is in stage II, which is 29.42 minutes, with service hours at 14.00-20.00. This is not efficient when compared to the standard value of compound drugs < 30 minutes and non-concoction drugs 15 minutes.The percentage of drugs not served is0.0085% it has not been effective with an indicator of 0%.
APA, Harvard, Vancouver, ISO, and other styles
3

Khadka, Sitaram, Hamid Saeed, Janak Shahi, Yogesh Bajgain, Tank Prasad Yadav, and Ravi Prasad Gupta. "Utilizing Hospital Formulary System in Nepal." Journal of Nepal Health Research Council 18, no. 2 (September 8, 2020): 337–39. http://dx.doi.org/10.33314/jnhrc.v18i2.2647.

Full text
Abstract:
Since the early 1950s, for medication management, the hospital formulary system subsisted as a list of drugs into the supply chain management process in hospitals. With the advent of pharmacy practice services, the system now is more oriented towards the rational use of drugs taking into account the safety of therapy, cost-effectiveness, and uninterrupted availability of drugs to improve and reflect upon the clinical judgment of healthcare professionals. Though very few hospitals in Nepal have adopted hospital formulary system, the perfect practice is still skimpy. The formation of drug and therapeutic committee along with the establishment of hospital pharmacy services is a growing trend with the arrival of hospital pharmacy guidelines 2072, thus, a positive spill-over of the hospital formulary system to each hospital in Nepal would be valuable in promoting rational drug therapy.Keywords: Cost-effectiveness; hospital formulary system, rational drug therapy.
APA, Harvard, Vancouver, ISO, and other styles
4

Singh, Uday, Gurjeet Singh, and Randhir Singh. "A STUDY ON DRUG UTILIZATION PATTERN OF ANTIHYPERTENSIVE DRUGS IN TERTIARY CARE HOSPITAL." INDIAN RESEARCH JOURNAL OF PHARMACY AND SCIENCE 7, no. 2 (June 2020): 2184–93. http://dx.doi.org/10.21276/irjps.2020.7.2.11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Muijen, M., and T. Silverstone. "A Comparative Hospital Survey of Psychotropic Drug Prescribing." British Journal of Psychiatry 150, no. 4 (April 1987): 501–4. http://dx.doi.org/10.1192/bjp.150.4.501.

Full text
Abstract:
In a survey of psychotropic drug prescribing for in-patients in three different types of psychiatric hospitals, the prevalence of combinations of more than one psychotropic drug varied from 45% in one hospital to 94% in another, with significant consistent differences between the use of drug combinations in the various hospitals. Combinations of two antipsychotic drugs were particularly frequent; the hospital with the lowest prevalence of polypharmacy was the only one with an associated psychopharmacology unit. Access to clinical pharmacology teaching may be an important factor in determining appropriate drug-prescribing habits.
APA, Harvard, Vancouver, ISO, and other styles
6

Nydert, Per, and Robert Poole. "Exploring Differences in Inpatient Drug Purchasing Cost Between Two Pediatric Hospitals." Journal of Pediatric Pharmacology and Therapeutics 17, no. 4 (December 1, 2012): 374–81. http://dx.doi.org/10.5863/1551-6776-17.4.374.

Full text
Abstract:
OBJECTIVES In this study, the hospital cost of purchasing drugs at two children's hospitals is explored with respect to high-cost drugs and drug classes and discussed with regard to differences in hospital setting, drug price, or number of treatments. METHODS The purchasing costs of drugs at the two hospitals were retrieved and analyzed. All information was connected to the Anatomic Therapeutic Chemical code and compared in a Microsoft Access database. RESULTS The 6-month drug purchasing costs at Astrid Lindgren Children's Hospital (ALCH), Stockholm, Sweden, and Lucile Packard Children's Hospital at Stanford (LPCH), Palo Alto, California, are similar and result in a cost per patient day of US $149 and US $136, respectively. The hospital setting and choice of drug products are factors that influence the drug cost in product-specific ways. CONCLUSIONS Several problems are highlighted when only drug costs are compared between hospitals. For example, the comparison does not take into account the amount of waste, risk of adverse drug events, local dosing strategies, disease prevalence, and national drug-pricing models. The difference in cost per inpatient day at ALCH may indicate that cost could be redistributed in Sweden to support pediatric pharmacy services. Also, when introducing new therapies seen at the comparison hospital, it may be possible to extrapolate the estimated increase in cost.
APA, Harvard, Vancouver, ISO, and other styles
7

Savitsky, Maureen E. "Recognizing Hospital Adverse Drug Reactions." Journal of Pharmacy Practice 2, no. 4 (August 1989): 203–8. http://dx.doi.org/10.1177/089719008900200402.

Full text
Abstract:
Adverse drug reactions (ADRs) are a frequently overlooked complication of drug therapy. The categories of drugs most commonly implicated include anticoagulants, antimicrobials, cardiac agents, CNS agents, diagnostic agents, nonsteroidal antiinflammatory agents, and hormones. In addition to knowing what drug classes most commonly produce ADRs, the clinician should also recognize what drugs are most frequently associated with specific ADRs. Anaphylaxis is one of the most serious, and potentially life-threatening, ADRs. Treatment of an anaphylactic reaction involves correcting the physiologic effects of released chemical mediators and also inhibiting the release of additional mediators. The mainstay of therapy is aqueous epinephrine. Severe reactions may require administration of aminophylline, inotropic agents, antihistamines, corticosteroids, and intravenous fluids. The best treatment for any ADR is prevention. Pharmacists can actively participate in the monitoring of risk factors, especially the number of drugs in a regimen, potential drug interactions, and drug allergies, which may predispose patients to ADR development. Pharmacists can also assist in the detection of ADRs by monitoring alerting orders. Other potential activities for pharmacists include providing timely and accurate information about ADRs ; educating patients, physicians, and other health care professionals; and influencing prescribing patterns to minimize the trend towards polypharmacy.
APA, Harvard, Vancouver, ISO, and other styles
8

Einarson, Thomas R. "Drug-Related Hospital Admissions." Annals of Pharmacotherapy 27, no. 7-8 (July 1993): 832–40. http://dx.doi.org/10.1177/106002809302700702.

Full text
Abstract:
OBJECTIVE: To review and summarize studies reporting rates of drug-related hospital admissions. DATA SOURCES: Manual and computerized literature searches using MEDLINE, Index Medicus, and International Pharmaceutical Abstracts as databases (key words: Drug, drug-related, or iatrogenic; admission, hospital admission, or hospitalization; and ADR or adverse drug reaction). References from retrieved articles were searched to locate further studies. STUDY SELECTION: Included were English-language studies of humans admitted to the hospital because of medications. Problems investigated were admissions prompted by adverse drug reactions (ADRs) when drugs were used by the patient and admissions resulting from a patient's noncompliant or unintentionally inappropriate drug use. Excluded were cases involving drug abuse, alcoholism, suicide attempts, intoxication, or inadequate prescribing. DATA SYNTHESIS: Between 1966 and 1989, ADR rates from 49 hospitals or groups of hospitals in a variety of international settings were published in 36 articles. Sample sizes ranged from 41 to 11 891 patients, with a median of 714 (interquartile range [IQR] 275-1245) and a mean of 1412 (SD 2233). The prevalence of reported admissions resulting from ADRs ranged from 0.2 to 21.7 percent; the median was 4.9 percent (IQR 2.9–6.7 percent) and the mean was 5.5 percent (SD 4.1 percent). The weighted meta-analytic estimate was 5.1 percent (95 percent confidence interval 4.4–5.8). Of those ADR admissions, 71.5 percent were side effects, 16.8 percent excessive effects, 11.3 percent hypersensitivity reactions, and 0.4 percent idiosyncratic; 3.7 percent of patients admitted for ADRs died. Eleven reports indicated that 22.7 percent of ADR hospitalizations were induced by noncompliance. CONCLUSIONS: Drug-induced hospitalizations account for approximately five percent of all admissions. Results apply only to people from highly developed industrialized countries. Economic analyses have not been performed. Future research should include the Third World and nonindustrialized nations as well as specific cultural groups.
APA, Harvard, Vancouver, ISO, and other styles
9

Leiman, Sheldon. "HOSPITAL DRUG QUIZ." Nursing 17, no. 2 (February 1987): 31–32. http://dx.doi.org/10.1097/00152193-198702000-00013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hyams, Peter A. "HOSPITAL DRUG QUIZ." Nursing 17, no. 5 (May 1987): 26–27. http://dx.doi.org/10.1097/00152193-198705000-00013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hospital; drug"

1

Misan, Gary M. H. "Hospital drug usage evaluation /." Cover title, title page, table of contents and abstract only, 1997. http://web4.library.adelaide.edu.au/theses/09PH/09phm6776.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Reimche, Leanne D. "Potential drug-drug interactions in a Canadian tertiary-care hospital." Thesis, University of Ottawa (Canada), 2008. http://hdl.handle.net/10393/27724.

Full text
Abstract:
Drug-Drug interactions (DDIs) are an important focus of patient safety because they account for a substantial number of adverse drug events and are preventable. Objective. To study DDIs in a Canadian hospital, a retrospective observational study was completed using the Ottawa Hospital Data Warehouse. Study cohort. Admissions to the Ottawa hospital between January 1, 1999 and September 30, 2005. Methods. Potential drug-drug interactions were identified by examining all co-administered medications for combinations of drugs previously reported to have potential interactions. Poisson regression was used to examine potential patient and hospital factors associated with drug-drug interactions. Results. Between 1999 and 2005, we found at least one DDI in 19.3% of all hospitalizations and 18.8% of hospitalization time. Category 1 (drug combinations to be avoided) and Category 2 (drug combinations usually avoided) interactions were rare, accounting for only 0.022% and 1.4% of hospitalization time, respectively. Category 3 interactions (drug combinations requiring alteration) occurred with 5.7% of all drug orders and were present for 17.4% of hospitalization time. Poisson regression analysis found that DDIs were significantly more likely to occur in patients who were: older; admitted to a surgical service; had a greater number of comorbidities; and were prescribed a greater number of drugs. Conclusion. Drug-Drug interactions occurred frequently during hospitalization. Future study is required to determine if the interactions identified are associated with important clinical outcomes.
APA, Harvard, Vancouver, ISO, and other styles
3

Davies, Emma Clare. "Adverse drug reactions in hospital inpatients." Thesis, Liverpool John Moores University, 2008. http://researchonline.ljmu.ac.uk/5900/.

Full text
Abstract:
Adverse drug reactions (ADRs) are a significant public health problem. This thesis examined the incidence and nature of adverse drug reactions following admission to hospital. An initial pilot study was conducted to develop methodology, which was then utilised in a study of 3695 patients. Approximately 15% of patients experienced an ADR following admission, of which one-third were serious Commonly used drugs such as opioids, diuretics and anticoagulants were the most frequent causes of ADRs. Bleeding, renal impairment and Clostridium difficile were the ADRs with the greatest impact on patient length of stay and thus should be key areas for intervention strategies. Adoption of methods used in the assessment of hospital patient safety incidents such as root-cause analysis may help in identifying underlying factors leading to ADRs as well highlighting the importance of ADRs to senior hospital managers.
APA, Harvard, Vancouver, ISO, and other styles
4

Ramos, Gregg (Gregg Allen). "Reducing preventable adverse drug events in hospital settings." Thesis, Massachusetts Institute of Technology, 2007. http://hdl.handle.net/1721.1/40113.

Full text
Abstract:
Thesis (M. Eng. in Logistics)--Massachusetts Institute of Technology, Engineering Systems Division, 2007.
Includes bibliographical references (leaves 51-53).
It has been estimated that on average, every patient admitted to a hospital is subject to at least one medication error per day (IOM, 2006). Errors may occur during various stages of the Medication Use System; a system composed of various tasks performed from the point of prescribing medication to the point in which a patient is monitored for adverse effects. Studies have shown that a majority of the errors that occur during the Medication Use System have little if any adverse effect on patients. However, there are classes of medication errors known as Adverse Drug Events (ADE's) which can cause significant harm to a patient. ADE's are not only dangerous but they have been estimated to cost the health care industry and the public in excess of $3.5 billion dollars per year (IOM, 2007). While extensive, current literature that exists on preventable ADE's varies greatly in regards how prevalent the issue is. The lack of a nationwide information system for identifying and defining ADE's only exacerbates the problem. In addition, when significant errors do occur, the repercussions for clinicians and hospitals are far from proportional. Several studies suggest that over one quarter of all medication related injuries are preventable (IOM, 2007).
(cont.) Many industry observers have long touted computerized information systems as the Holy Grail for reducing medication errors. While there is little question that computerized systems can reduce ADE's, hospitals and clinicians frequently ignore other solutions that can offer greater impact in improving the level of care that is being provided. The health care industry has long been touted as fostering a culture that supports at risk behavior and shuns the use of standardized processes. The lack of transparency into the health care industry coupled with an unwillingness to embrace cultural change continues to be one of the largest barriers in reducing the number of preventable ADE's. This paper recommends 4 different solutions that will change the culture of the health care industry, incent hospitals to focus on reducing preventable ADE's, improve the processes already in place for providing patient care and provide clinicians with the most up to date health care information available.
by Gregg Ramos.
M.Eng.in Logistics
APA, Harvard, Vancouver, ISO, and other styles
5

Terry, Allan Keith 1952. "National survey of hospital drug-use evaluation programs." Thesis, The University of Arizona, 1992. http://hdl.handle.net/10150/291364.

Full text
Abstract:
A self-administered, mail questionnaire was used to assess the current state of hospital drug-use evaluation (DUE) programs within short-term, general U.S. hospitals. During February-March 1992, two mailings were sent to pharmacy directors at 491 randomly selected institutions. A net response rate of 66.6% (327/491) was achieved. The level of pharmacist participation in DUE program activities was found to be very high and to have a significant, positive correlation with the rated effectiveness of current DUE programs and the rated importance of pharmacist participation in DUE program activities. Pharmacists were members on 97.9% of responders' DUE (sub)committees, while 65.5% of pharmacist members held voting privileges. Pharmacists devoted an average of 11.27 hours per week to DUE-related tasks. Wide variation was demonstrated in rationale used to select DUE study drugs, interventions employed, use of DUE study results, and methods selected to evaluate DUE program effectiveness.
APA, Harvard, Vancouver, ISO, and other styles
6

Howard, Rachel. "The underlying causes of preventable drug-related hospital admissions." Thesis, University of Nottingham, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.437084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Meiring, Jillian A. "Antimicrobial resistance patterns in a Port Elizabeth hospital." Thesis, Rhodes University, 1993. http://hdl.handle.net/10962/d1004104.

Full text
Abstract:
Antibiotic resistance in clinical bacterial isolates remains an ongoing problem requiring continuous monitoring to effect some form of control. Comparative studies have not been previously reported for the Eastern Cape Region, South Africa and this study was undertaken to monitor resistance patterns in clinical isolates from Provincial Hospital, Port Elizabeth. Over the three year period 1989 to 1991, 9888 susceptibility results from isolates examined in the SAIMR pathology laboratory were analysed and collated using a stand-alone computer program. Resistance patterns for a range of nineteen antibiotics were collated for isolates from various sampling points within the hospital. Results were reported as resistance patterns in individually isolated species. Levels of resistance in each species were compared to those reported from South Africa and abroad, and changing patterns of resistance were noted within the three year period at the Provincial Hospital, Port Elizabeth.
APA, Harvard, Vancouver, ISO, and other styles
8

Green, Christopher Francis. "Hospital pharmacists and their role in adverse drug reaction reporting." Thesis, Liverpool John Moores University, 2000. http://researchonline.ljmu.ac.uk/5124/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rübesam, Tim. "Drug funding decision-making in hospital formulary committees in Germany." Thesis, University of Gloucestershire, 2015. http://eprints.glos.ac.uk/3432/.

Full text
Abstract:
BACKGROUND: Hospital formularies are usually the gatekeepers for pharmaceutical drugs. Typical majority members of hospital formularies are physicians, although most of the time the formulary is chaired by a pharmacist. As German hospitals are struggling with a difficult economic environment the question arises: what kind of decision-making criteria are applied when pharmaceutical drugs should be added to the formulary list? Information regarding this topic is scarce due to the sensitive topic of decision-making. OBJECTIVES: Build a single decision-making framework which will be created to explain hospital drug funding decision-making and identify underlying mechanisms which explain processes and structures. The results can be used by hospitals to initiate knowledge sharing and provide a basis to analyse local formulary committee decision-making practice. Additionally, they can be used by the pharmaceutical industry to better adapt to the specific needs of the hospital decision-makers. METHODS: In this study, a mixed-methods approach has been used to confirm and further detail a preliminary hospital formulary decision-making framework derived from literature. An online survey was used to get insights on the structure of German hospital formularies and the relative importance of different decision-criteria. Additional semi-structured expert interviews were used to get in-depth information on the underlying mechanisms which influence decision-making on drug funding. RESULTS: Decisions for or against a pharmaceutical drug are influenced by a variety of perceived objective and specifically subjective criteria. Despite a consistency in a dominant, high impact role of pharmacists and lead physicians every hospital formulary member has different relative weighting of decision criteria. Drug funding decision-making in German hospital formularies is highly individual but usually starts with a quasi-rational preference influenced by a mixture of analytic and intuitive criteria. The decision to use more analytic or more intuitive criteria is influenced by a variety of factors. The two most important ones are uncertainty and power. The resulting individual preference is then challenged and adapted in a group decision-making process.
APA, Harvard, Vancouver, ISO, and other styles
10

Minn, Minn Soe. "Drug resistant tuberculosis in patients with AIDS at Bamrasnaradura hospital /." Abstract, 1999. http://mulinet3.li.mahidol.ac.th/thesis/2542/42E-MinnMinnSoe.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Hospital; drug"

1

Leung, Michael. Drug-related hospital admissions. Hamilton: St. Joseph's Hospital, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

All-Wales Health Management Efficiency Group. Hospital drug expenditure in Wales. Mold: The Group, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Association, Ontario Hospital. A treatise on the Canadian (Ontario) hospital experience with the acquisition, distribution, prescribing and dispensing of drugs: Second submission by the Ontario Hospital Association to the Pharmaceutical Inquiry of Ontario. Don Mills, Ont: The Association, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Foisy, Michelle M. An Overview of Acetaminophen overdoses at the Ottawa General Hospital. [Ottawa: s.n., 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Canadian Society of Hospital Pharmacists. CSHP standards, guidelines, and statements: Addendum. Ottawa, Ont: Canadian Society of Hospital Pharmacists = Société canadienne des pharmaciens d'hôpitaux, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pharmacists, Canadian Society of Hospital. CSHP standards, guidelines, and statements. Ottawa, Ont: Canadian Society of Hospital Pharmacists = Société canadienne des pharmaciens d'hôpitaux, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hospital: A dream-vision. London: Hamish Hamilton, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hospital: A dream-vision. London: Penguin Books, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Brogan, Tom. 1983 drug store and hospital drug purchases: A comparison of Canada and the United States. Ottawa: Commission of Inquiry on the Pharmaceutical Industry; Supply and Services Canada, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nelson, Cheryl. Alcohol- and drug-related visits to hospital emergency departments: 1992 National Hospital Ambulatory Medical Care Survey. [Hyattsville, Md.] (6525 Belcrest Rd., Hyattsville 20782): [U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Hospital; drug"

1

Fung, Maxwell A., Danielle M. Tartar, and Alain Brassard. "Drug Reactions." In Hospital-Based Dermatopathology, 695–756. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-35820-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jones, Judith K. "Hospital Data Sources." In Drug Epidemiology and Post-Marketing Surveillance, 83–90. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4899-2587-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Beard, Keith. "Hospital-Based Intensive Cohort Studies." In Drug Epidemiology and Post-Marketing Surveillance, 91–98. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4899-2587-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lee, Maxwell, Jay Karri, Mayank Gupta, Michelle Poliak-Tunis, and Alaa Abd-Elsayed. "Urine Drug Screening in the Hospital Setting." In Guide to the Inpatient Pain Consult, 609–15. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-40449-9_42.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bearman, Gonzalo M. L., and Richard P. Wenzel. "Hospital Infection Control: Considerations for the Management and Control of Drug-Resistant Organisms." In Antimicrobial Drug Resistance, 1277–93. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-595-8_42.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Donovan, Summer, and Gonzalo M. L. Bearman. "Hospital Infection Control: Considerations for the Management and Control of Drug-Resistant Organisms." In Antimicrobial Drug Resistance, 1529–49. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47266-9_40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chang, Cheng-Ming. "Smart Counter of Hospital for Patient Drug Pickup." In Lecture Notes in Electrical Engineering, 601–5. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-3648-5_72.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cagliano, Anna Corinna, Sabrina Grimaldi, and Carlo Rafele. "A Decision-Making Approach Supporting Hospital Drug Logistics." In Proceedings of the International Conference on Health Care Systems Engineering, 241–52. Cham: Springer International Publishing, 2013. http://dx.doi.org/10.1007/978-3-319-01848-5_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fenwick, Alan, Wendie Norris, and Becky McCall. "Research, training and drug testing in Sudan, 1971-1988." In A tale of a man, a worm and a snail: the schistosomiasis control initiative, 25–41. Wallingford: CABI, 2021. http://dx.doi.org/10.1079/9781786392558.0004.

Full text
Abstract:
Abstract In Sudan, almost every town has a small hospital, described as a 'one-doctor hospital', and traditionally, the newly graduated doctors are assigned to a hospital for two years, where they learned a trade and lived there. The wards are quite sparse in the hospital. While this is good for male graduates, it is not well received by parents of female graduates because Sudanese tradition expects women to marry and give birth in finish their study. To meet the demand for doctors in rural communities, Some changes were needed, and the School of Medicine solved this problem somewhat. problem by limiting consumption to 50% of men and 50% of men. This book chapter describes a physician's experience with schistosomiasis research and testing.
APA, Harvard, Vancouver, ISO, and other styles
10

Bondolfi, G., and P. Bovet. "AIDS Risk Behavior Among Intravenous Drug Users Hospitalized in a Public Psychiatric Hospital." In Drug Addiction and AIDS, 384–87. Vienna: Springer Vienna, 1991. http://dx.doi.org/10.1007/978-3-7091-9173-6_44.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hospital; drug"

1

Yamao, Naoki, and Y. Okada. "An Analysis of Drug Administration Taskson Safety Management in Medical Centers." In Applied Human Factors and Ergonomics Conference. AHFE International, 2020. http://dx.doi.org/10.54941/ahfe100323.

Full text
Abstract:
The safety management in various hospitals recently has begun in order to reduce the incidents and prevent human errors. Among incidents that occurred in hospital, many are related to drug administration error. Drug administration error is a type of human error that occurs somewhere in the process spanning from medicine prescription by the doctor through administration by the nurse. We examined whether there is any problem with the incident report on the drug administration error in the hospital. Then, we found that it is difficult for safety manager with little experience, to find the problems in drug administration task. Also we found that they didn’t know how they would discuss countermeasures. Therefore we studied to help safety manager find and take measure in work including dangerous factors at drug administration tasks by evaluating the risk of the work. The method is evaluating the risk of the work in the drug administration tasks by using Factors List, Risk Score and Influence of the Factors. By using this method, it helps safety managers in the hospitals understand problems of the work in the drug administration tasks and activate the recurrence prevention activities of medical accident.
APA, Harvard, Vancouver, ISO, and other styles
2

Cunnington, P., C. Griffith, and A. Kenney. "A1.2 Great ormond street hospital anaesthesia drug guidelines: from print to smartphone." In Great Ormond Street Hospital Conference. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-084620.2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zovi, A., C. Inserra, M. Piacenza, and V. Stefania. "2SPD-022 Drug shortages and drug unavailability: analysis from an Italian hospital." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Turjap, M., O. Nedopílková, and J. Juřica. "6ER-037 Drug–drug interactions with QT prolonging drugs in patients admitted to a cardiovascular department: a retrospective analysis." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.361.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rajbhandari, G. L., H. Rataul, and G. R. Pesola. "Cardiac Arrest from In-Hospital Surreptitious Drug Overdose." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1903.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jinxin, Chen, Li Zhenghao, and Wang Yimin. "Research on Hospital Drug Supply Chain Management Mode." In 2020 International Conference on Robots & Intelligent System (ICRIS). IEEE, 2020. http://dx.doi.org/10.1109/icris52159.2020.00058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Soman, Sumit, Priyesh Ranjan, Amarjeet Singh Cheema, and Praveen K. Srivastava. "Integrating Drug Terminologies with Hospital Management Information Systems." In 2019 10th International Conference on Computing, Communication and Networking Technologies (ICCCNT). IEEE, 2019. http://dx.doi.org/10.1109/icccnt45670.2019.8944833.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Faizah, Ana Khusnul, and Nani Wijayanti Dyah Nurrahman. "Evaluation of Potential Drug-Drug Interactions in Hypercholesterolemia Patients at Teaching Hospital Surabaya." In 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/ahsr.k.210115.064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Velasco Costa, J., EM Robles Blazquez, JM Peñalver Gonzalez, and M. Martinez De Guzman. "2SPD-037 Analysis of drug dispenses outside the hospital guide in a psychiatric hospital." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Proy Vega, B., MM Alañon Pardo, C. Notario Dongil, MC Conde Garcia, and ML Moreno Perulero. "2SPD-032 Drug exchange network." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.25.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Hospital; drug"

1

Alalqam, Razi, Hussain Al Mashhad, and Frank Doyle. Clinician-Reported Barriers to the Provision of Brief Advice for Drug Use in Hospital Inpatient Settings. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2021. http://dx.doi.org/10.37766/inplasy2021.2.0035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rosa-Mangeret, Flavia, Otis Olela, Francisca Barcos-Munoz, Noemie Wagner, Olivier Duperrex, Marc Dupuis, and Riccardo E. Pfister. Drug Resistant Bacterial Neonatal Early Onset Sepsis in Africa: A 20 year- prevalence review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0112.

Full text
Abstract:
Review question / Objective: What is the prevalence of drug-resistant pathogens associated with neonatal Early Onset Sepsis (NEOS) in the African continent and their likelihood of resistance to commonly used antibiotics in the NEOS, and what is the trend through time? Condition being studied: There is no consensus on the definition of neonatal sepsis. Two main categories of neonatal sepsis are widely accepted: early-onset sepsis (EOS) defined as occurring in the first 72 hours of life, hence representing perinatal vertical infection; and late-onset sepsis (LOS), which occurs between 72 hours to 28 days and can be hospital or community-acquired. Information sources: Pubmed, EMBASE, Web of Science. All authors from papers with missing information were contacted before article exclusion.
APA, Harvard, Vancouver, ISO, and other styles
3

Motley, Robert, Rebekah Siddiqi, Awanti Acharya, Eric Williamson, Danielle Walker, and Kaycee Bills. A 21st Century Look at Threats to the Personal Safety of Emerging Adults in Massachusetts. Boston College School of Social Work, Racism-based Violence Injury & Prevention Lab, May 2022. http://dx.doi.org/10.6017/ssw.rbvipl.rb001.kq8472.

Full text
Abstract:
Trends in homicide rates for emerging adults in Massachusetts was examined using data from the Massachusetts Violent Death Reporting System, Injury Surveillance Program, and Massachusetts Department of Public Health. Data for police killings was drawn from Mapping Police Violence which currently represents one of the most comprehensive databases of police killing victims in the U.S. Data from Analyze Boston was used to examine rates of police contacts that involved non-fatal police contacts (frisk or searches) among emerging adults in Boston, Massachusetts. Data for suicide deaths and mechanism of suicide were drawn from the Massachusetts Violent Death Reporting System, Injury Surveillance Program, Massachusetts Department of Public Health. Counts of Emergency Department visits for nonfatal drug overdoses in Massachusetts were drawn from the Massachusetts Inpatient Hospital Discharge, Outpatient Observation Stay, and Outpatient Emergency Department Discharge Databases, via the Center for Health Information and Analysis.
APA, Harvard, Vancouver, ISO, and other styles
4

Bhatt, Mihir R., Shilpi Srivastava, Megan Schmidt-Sane, and Lyla Mehta. Key Considerations: India's Deadly Second COVID-19 Wave: Addressing Impacts and Building Preparedness Against Future Waves. Institute of Development Studies (IDS), June 2021. http://dx.doi.org/10.19088/sshap.2021.031.

Full text
Abstract:
Since February 2021, countless lives have been lost in India, which has compounded the social and economic devastation caused by the second wave of COVID-19. The sharp surge in cases across the country overwhelmed the health infrastructure, with people left scrambling for hospital beds, critical drugs, and oxygen. As of May 2021, infections began to come down in urban areas. However, the effects of the second wave continued to be felt in rural areas. This is the worst humanitarian and public health crisis the country has witnessed since independence; while the continued spread of COVID-19 variants will have regional and global implications. With a slow vaccine rollout and overwhelmed health infrastructure, there is a critical need to examine India's response and recommend measures to further arrest the current spread of infection and to prevent and prepare against future waves. This brief is a rapid social science review and analysis of the second wave of COVID-19 in India. It draws on emerging reports, literature, and regional social science expertise to examine reasons for the second wave, explain its impact, and highlight the systemic issues that hindered the response. This brief puts forth vital considerations for local and national government, civil society, and humanitarian actors at global and national levels, with implications for future waves of COVID-19 in low- and middle-income countries. This review is part of the Social Science in Humanitarian Action Platform (SSHAP) series on the COVID-19 response in India. It was developed for SSHAP by Mihir R. Bhatt (AIDMI), Shilpi Srivastava (IDS), Megan Schmidt-Sane (IDS), and Lyla Mehta (IDS) with input and reviews from Deepak Sanan (Former Civil Servant; Senior Visiting Fellow, Centre for Policy Research), Subir Sinha (SOAS), Murad Banaji (Middlesex University London), Delhi Rose Angom (Oxfam India), Olivia Tulloch (Anthrologica) and Santiago Ripoll (IDS). It is the responsibility of SSHAP.
APA, Harvard, Vancouver, ISO, and other styles
5

Hajarizadeh, Behzad, Jennifer MacLachlan, Benjamin Cowie, and Gregory J. Dore. Population-level interventions to improve the health outcomes of people living with hepatitis B: an Evidence Check brokered by the Sax Institute for the NSW Ministry of Health, 2022. The Sax Institute, August 2022. http://dx.doi.org/10.57022/pxwj3682.

Full text
Abstract:
Background An estimated 292 million people are living with chronic hepatitis B virus (HBV) infection globally, including 223,000 people in Australia. HBV diagnosis and linkage of people living with HBV to clinical care is suboptimal in Australia, with 27% of people living with HBV undiagnosed and 77% not receiving regular HBV clinical care. This systematic review aimed to characterize population-level interventions implemented to enhance all components of HBV care cascade and analyse the effectiveness of interventions. Review questions Question 1: What population-level interventions, programs or policy approaches have been shown to be effective in reducing the incidence of hepatitis B; and that may not yet be fully rolled out or evaluated in Australia demonstrate early effectiveness, or promise, in reducing the incidence of hepatitis B? Question 2: What population-level interventions and/or programs are effective at reducing disease burden for people in the community with hepatitis B? Methods Four bibliographic databases and 21 grey literature sources were searched. Studies were eligible for inclusion if the study population included people with or at risk of chronic HBV, and the study conducted a population-level interventions to decrease HBV incidence or disease burden or to enhance any components of HBV care cascade (i.e., diagnosis, linkage to care, treatment initiation, adherence to clinical care), or HBV vaccination coverage. Studies published in the past 10 years (since January 2012), with or without comparison groups were eligible for inclusion. Studies conducting an HBV screening intervention were eligible if they reported proportion of people participating in screening, proportion of newly diagnosed HBV (participant was unaware of their HBV status), proportion of people received HBV vaccination following screening, or proportion of participants diagnosed with chronic HBV infection who were linked to HBV clinical care. Studies were excluded if study population was less than 20 participants, intervention included a pharmaceutical intervention or a hospital-based intervention, or study was implemented in limited clinical services. The records were initially screened by title and abstract. The full texts of potentially eligible records were reviewed, and eligible studies were selected for inclusion. For each study included in analysis, the study outcome and corresponding 95% confidence intervals (95%CIs) were calculated. For studies including a comparison group, odds ratio (OR) and corresponding 95%CIs were calculated. Random effect meta-analysis models were used to calculate the pooled study outcome estimates. Stratified analyses were conducted by study setting, study population, and intervention-specific characteristics. Key findings A total of 61 studies were included in the analysis. A large majority of studies (study n=48, 79%) included single-arm studies with no concurrent control, with seven (12%) randomised controlled trials, and six (10%) non-randomised controlled studies. A total of 109 interventions were evaluated in 61 included studies. On-site or outreach HBV screening and linkage to HBV clinical care coordination were the most frequent interventions, conducted in 27 and 26 studies, respectively. Question 1 We found no studies reporting HBV incidence as the study outcome. One study conducted in remote area demonstrated that an intervention including education of pregnant women and training village health volunteers enhanced coverage of HBV birth dose vaccination (93% post-intervention, vs. 81% pre-intervention), but no data of HBV incidence among infants were reported. Question 2 Study outcomes most relevant to the HBV burden for people in the community with HBV included, HBV diagnosis, linkage to HBV care, and HBV vaccination coverage. Among randomised controlled trials aimed at enhancing HBV screening, a meta-analysis was conducted including three studies which implemented an intervention including community face-to-face education focused on HBV and/or liver cancer among migrants from high HBV prevalence areas. This analysis demonstrated a significantly higher HBV testing uptake in intervention groups with the likelihood of HBV testing 3.6 times higher among those participating in education programs compared to the control groups (OR: 3.62, 95% CI 2.72, 4.88). In another analysis, including 25 studies evaluating an intervention to enhance HBV screening, a pooled estimate of 66% of participants received HBV testing following the study intervention (95%CI: 58-75%), with high heterogeneity across studies (range: 17-98%; I-square: 99.9%). A stratified analysis by HBV screening strategy demonstrated that in the studies providing participants with on-site HBV testing, the proportion receiving HBV testing (80%, 95%CI: 72-87%) was significantly higher compared to the studies referring participants to an external site for HBV testing (54%, 95%CI: 37-71%). In the studies implementing an intervention to enhance linkage of people diagnosed with HBV infection to clinical care, the interventions included different components and varied across studies. The most common component was post-test counselling followed by assistance with scheduling clinical appointments, conducted in 52% and 38% of the studies, respectively. In meta-analysis, a pooled estimate of 73% of people with HBV infection were linked to HBV clinical care (95%CI: 64-81%), with high heterogeneity across studies (range: 28-100%; I-square: 99.2%). A stratified analysis by study population demonstrated that in the studies among general population in high prevalence countries, 94% of people (95%CI: 88-100%) who received the study intervention were linked to care, significantly higher than 72% (95%CI: 61-83%) in studies among migrants from high prevalence area living in a country with low prevalence. In 19 studies, HBV vaccination uptake was assessed after an intervention, among which one study assessed birth dose vaccination among infants, one study assessed vaccination in elementary school children and 17 studies assessed vaccination in adults. Among studies assessing adult vaccination, a pooled estimate of 38% (95%CI: 21-56%) of people initiated vaccination, with high heterogeneity across studies (range: 0.5-93%; I square: 99.9%). A stratified analysis by HBV vaccination strategy demonstrated that in the studies providing on-site vaccination, the uptake was 78% (95%CI: 62-94%), significantly higher compared to 27% (95%CI: 13-42%) in studies referring participants to an external site for vaccination. Conclusion This systematic review identified a wide variety of interventions, mostly multi-component interventions, to enhance HBV screening, linkage to HBV clinical care, and HBV vaccination coverage. High heterogeneity was observed in effectiveness of interventions in all three domains of screening, linkage to care, and vaccination. Strategies identified to boost the effectiveness of interventions included providing on-site HBV testing and vaccination (versus referral for testing and vaccination) and including community education focussed on HBV or liver cancer in an HBV screening program. Further studies are needed to evaluate the effectiveness of more novel interventions (e.g., point of care testing) and interventions specifically including Indigenous populations, people who inject drugs, men who have sex with men, and people incarcerated.
APA, Harvard, Vancouver, ISO, and other styles
6

Evaluation of chemotherapy drug exposure in a veterinary specialty hospital. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, August 2019. http://dx.doi.org/10.26616/nioshhhe201602313354.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Health hazard evaluation report: chemotherapy drug evaluation at a veterinary teaching hospital - Michigan. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, April 2013. http://dx.doi.org/10.26616/nioshheta201000683156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Introducing magnesium sulphate for the management of pregnancy induced hypertension. Population Council, 2005. http://dx.doi.org/10.31899/rh16.1012.

Full text
Abstract:
Global studies have demonstrated that using magnesium sulphate (MgSO4) to manage hypertensive disease in pregnancy reduces morbidity and mortality due to severe pre-eclampsia/eclampsia, one of the five direct causes of maternal death. Many countries have been slow to introduce MgSO4 to the detriment of women’s health. There are also critical gaps in health-care provider knowledge, skills, and practice in management of eclampsia. Although the use of MgSO4 was introduced successfully to the Maternity Unit at Kenyatta National Hospital, Nairobi, in 2001, there has been no systematic introduction of the drug across the country. Generally, the only facilities utilizing MgSO4 are those supported by development partners and some mission hospitals. In response to requests from health-care managers and providers in Western Province to be trained in the use of MgSO4, a two-day practical training program was developed. As noted in this brief, the main objective of the training was to ensure that participants had specific skills for preventing and managing severe pre-eclampsia and eclampsia.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hospital; drug' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography